Understanding progerin-induced structural, functional, and molecular alterations to the vascular ECM, VSMCs, and ECs and their interactions is therefore crucial for the development of new vascular-targeted therapies for HGPS. Here, LMNA is linked to Hutchinson-Gilford progeria syndrome.